268 related articles for article (PubMed ID: 26837697)
1. A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia.
Skeith L; Carrier M; Kaaja R; Martinelli I; Petroff D; Schleußner E; Laskin CA; Rodger MA
Blood; 2016 Mar; 127(13):1650-5. PubMed ID: 26837697
[TBL] [Abstract][Full Text] [Related]
2. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
[TBL] [Abstract][Full Text] [Related]
3. THE ROLE OF LOW MOLECULAR WEIGHT HEPARIN IN WOMEN WITH HEREDITARY THROMBOPHILIA FOR GOOD PERINATAL OUTCOME.
Sokol V; Ivanišević M; Herman M; Đelmiš J
Acta Clin Croat; 2016 Jun; 55(2):309-15. PubMed ID: 28394549
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
Areia AL; Fonseca E; Areia M; Moura P
Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
[TBL] [Abstract][Full Text] [Related]
6. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis.
Potdar N; Gelbaya TA; Konje JC; Nardo LG
Hum Reprod Update; 2013; 19(6):674-84. PubMed ID: 23912476
[TBL] [Abstract][Full Text] [Related]
7. Hold your needles in women with recurrent pregnancy losses with or without hereditary thrombophilia: Meta-analysis and review of the literature.
Intzes S; Symeonidou M; Zagoridis K; Stamou M; Spanoudaki A; Spanoudakis E
J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101935. PubMed ID: 33035720
[TBL] [Abstract][Full Text] [Related]
8. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E
J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962
[No Abstract] [Full Text] [Related]
9. Thromboprophylaxis implementation during pregnancy in women with recurrent foetal losses and thrombophilia.
Mitić G; Novakov Mikić A; Povazan L; Mitreski A; Kopitović V; Vejnović T
Med Pregl; 2011; 64(9-10):471-5. PubMed ID: 22097113
[TBL] [Abstract][Full Text] [Related]
10. Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial.
Quenby S; Booth K; Hiller L; Coomarasamy A; de Jong PG; Hamulyák EN; Scheres LJ; van Haaps TF; Ewington L; Tewary S; Goddijn M; Middeldorp S; ;
Lancet; 2023 Jul; 402(10395):54-61. PubMed ID: 37271152
[TBL] [Abstract][Full Text] [Related]
11. The long and winding road ... towards LMWH for pregnancy loss.
Gris JC; Marès P
J Thromb Haemost; 2005 Feb; 3(2):224-6. PubMed ID: 15670023
[No Abstract] [Full Text] [Related]
12. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
Ghosh K; Shetty S; Vora S; Salvi V
Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic therapy for pregnancy loss.
de Jong PG; Goddijn M; Middeldorp S
Hum Reprod Update; 2013; 19(6):656-73. PubMed ID: 23766357
[TBL] [Abstract][Full Text] [Related]
14. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss.
Rottenstreich A; Amsalem H; Kleinstern G; Kalish Y
Reprod Biomed Online; 2017 Oct; 35(4):461-467. PubMed ID: 28756129
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study.
Brenner B; Hoffman R; Carp H; Dulitsky M; Younis J;
J Thromb Haemost; 2005 Feb; 3(2):227-9. PubMed ID: 15670024
[No Abstract] [Full Text] [Related]
17. Comparative incidence of pregnancy outcomes in thrombophilia-positive women from the NOH-APS observational study.
Bouvier S; Cochery-Nouvellon E; Lavigne-Lissalde G; Mercier E; Fabbro-Peray P; Balducchi JP; Marès P; Gris JC
Blood; 2014 Jan; 123(3):414-21. PubMed ID: 24200686
[TBL] [Abstract][Full Text] [Related]
18. Preventing pregnancy loss.
Connors JM
Blood; 2014 Jan; 123(3):308-10. PubMed ID: 24434995
[TBL] [Abstract][Full Text] [Related]
19. Inherited thrombophilia and poor pregnancy outcome.
Brenner B; Kupferminc MJ
Best Pract Res Clin Obstet Gynaecol; 2003 Jun; 17(3):427-39. PubMed ID: 12787536
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 2 approaches in management of pregnant women with inherited trombophilias: Prospective analytical cohort study.
Dugalic S; Petronijevic M; Stefanovic A; Stefanovic K; Petronijevic SV; Stanisavljevic D; Kepeci SP; Milincic N; Pantic I; Perovic M
Medicine (Baltimore); 2019 Aug; 98(34):e16883. PubMed ID: 31441864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
